Metabolic Disease News and Research

RSS

Yale scientists develop advanced CRISPR tool to study complex genetic interactions

Yale scientists develop advanced CRISPR tool to study complex genetic interactions

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.

20 Mar 2025

Nwd1 gene linked to liver dysfunction in metabolic disease

Nwd1 gene linked to liver dysfunction in metabolic disease

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.

11 Mar 2025

Exploring the use of AI for precision hypertension management in diabetes care

Exploring the use of AI for precision hypertension management in diabetes care

Pennington Biomedical Research Center's Dr. Yun Shen will lead a team to explore the use of AI for precision hypertension management in Type-2 diabetes care.

10 Mar 2025

Surgery first strategy could lead to better weight loss outcomes

Surgery first strategy could lead to better weight loss outcomes

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy could lead to better outcomes.

5 Mar 2025

Melatonin protects skeletal muscle from damage caused by "diabesity"

Melatonin protects skeletal muscle from damage caused by "diabesity"

An international study led by the University of Granada (UGR) has revealed that melatonin, known for its ability to regulate the sleep/wake cycle, can restore the composition of muscle fibers and protect skeletal muscle from damage caused by obesity and type 2 diabetes, known as "diabesity".

5 Mar 2025

Surprising study reveals dads’ weight and diet don’t impact baby’s size

Surprising study reveals dads’ weight and diet don’t impact baby’s size

A study shows paternal health factors like BMI and diet do not influence birth weight or length, emphasizing maternal diet's critical role in pregnancy.

4 Mar 2025

The Future of CBD research, marketing, and regulation

The Future of CBD research, marketing, and regulation

In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, discuss Atlantia’s expertise in clinical trials for CBD.

From Atlantia Clinical Trials 28 Feb 2025

Integrating video capsule endoscopy technology in probiotic research

Integrating video capsule endoscopy technology in probiotic research

To be decided by the editor

From Atlantia Clinical Trials 28 Feb 2025

The brain-gut microbiota axis: Impact on mental health & potential treatment avenues

The brain-gut microbiota axis: Impact on mental health & potential treatment avenues

To be decided by the editor

From Atlantia Clinical Trials 28 Feb 2025

Randomized clinical food trials: Best clinical practice, quality management & data processing

Randomized clinical food trials: Best clinical practice, quality management & data processing

The evolution of food clinical trials highlights the importance of quality management and ICH-GCP adherence in validating health claims and interventions.

From Atlantia Clinical Trials 28 Feb 2025

Stress & Distress: Designing clinical trials for maximum efficacy

Stress & Distress: Designing clinical trials for maximum efficacy

To be decided by the editor

From Atlantia Clinical Trials 28 Feb 2025

Atlantia Clinical Trials: Investigating the interrelation of microbiology and immunology

Atlantia Clinical Trials: Investigating the interrelation of microbiology and immunology

Atlantia Clinical Trials investigates the role of microbiomes in immunity, focusing on gut and lung interactions to develop innovative health solutions.

From Atlantia Clinical Trials 28 Feb 2025

Elderly populations: Global trends in the healthy aging market

Elderly populations: Global trends in the healthy aging market

To be decided by the editor

From Atlantia Clinical Trials 28 Feb 2025

FGF21 hormone drives protein-specific appetite and reward in the brain

FGF21 hormone drives protein-specific appetite and reward in the brain

When faced with multiple food options and ultimately choosing one, the factors of that decision-making process may be more physiological than previously assumed.

25 Feb 2025

Insilico Medicine reaches preclinical milestone in MASH drug discovery

Insilico Medicine reaches preclinical milestone in MASH drug discovery

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based biotechnology company focuses on developing innovative first-in-class drugs for treatment for metabolic dysfunction-associated steatohepatitis (MASH).

25 Feb 2025

Gut microbiome shifts from sugary drinks tied to higher diabetes risk

Gut microbiome shifts from sugary drinks tied to higher diabetes risk

Researchers examine the association between sugar-sweetened beverage intake and gut microbiota-mediated changes that may mitigate the risk of diabetes.

7 Feb 2025

Adrenomedullin hormone contributes to insulin resistance in obesity-associated type 2 diabetes

Adrenomedullin hormone contributes to insulin resistance in obesity-associated type 2 diabetes

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.

6 Feb 2025

New method revolutionizes body composition analysis using 3D imaging and deep learning

New method revolutionizes body composition analysis using 3D imaging and deep learning

A recent study introduces an innovative method for analyzing body composition using advanced 3D imaging and deep learning techniques.

4 Feb 2025

Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs

Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest influences prescription trends.

3 Feb 2025

Improving insulin sensitivity with regular mango consumption

Improving insulin sensitivity with regular mango consumption

The regular consumption of mangoes may improve inflammation, insulin sensitivity, and glucose control.

3 Feb 2025

Previous
1
...
6
7
8
9
10
11
12
...
49
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.